Bristol-Myers Squibb

NYSE: BMY · Real-Time Price · USD
48.47
0.66 (1.38%)
At close: Aug 15, 2025, 3:59 PM
48.50
0.07%
After-hours: Aug 15, 2025, 07:58 PM EDT

Bristol-Myers Squibb Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
5.07B 5.44B -8.93B -7.25B -6.53B -6.13B 8.04B 8.3B 7.98B 7.33B 6.34B 6.69B 6.64B 6.27B 7.01B -5.38B -5.06B -6.2B
Depreciation & Amortization
6.5B 8.08B 9.6B 10.18B 10.03B 9.86B 9.76B 9.82B 9.97B 10.12B 10.28B 10.33B 10.47B 10.6B 10.69B 10.8B 10.72B 10.57B
Stock-Based Compensation
530M 518M 507M 514M 517M 529M 518M 510M 493M 472M 457M 471M 498M 539M 583M 621M 664M 720M
Other Working Capital
929M -421M 848M 1.52B 947M 361M -366M -2.2B -2.11B -1.52B -1.61B -876M -1.01B -723M -462M -573M -2.79B -2.02B
Other Non-Cash Items
3.94B 2.69B 15.29B 13.79B 13.87B 13.27B 744M 96M -333M 128M 955M 1.53B 1.9B 2.12B 575M 11.71B 10.28B 8.8B
Deferred Income Tax
-1.26B -1.16B -2.09B -2.63B -2.7B -3.45B -3.29B -2.58B -2.9B -2.6B -2.74B -3.38B -2.77B -2.15B -1.39B -563M -477M 1.1B
Change in Working Capital
1.13B -1.26B 810M 389M -1.03B -356M -1.91B -3.23B -3.35B -3.23B -2.23B -1.83B -1.34B -1.19B -1.26B -1.36B -3.31B -741M
Operating Cash Flow
15.9B 14.31B 15.19B 15B 14.16B 13.72B 13.86B 12.91B 11.85B 12.22B 13.07B 13.82B 15.4B 16.2B 16.21B 15.82B 12.82B 14.25B
Capital Expenditures
-1.32B -1.22B -1.25B -1.2B -1.22B -1.22B -1.21B -1.23B -1.13B -1.14B -1.12B -1.09B -1.11B -1.05B -973M -936M -819M -740M
Cash Acquisitions
343M -745M -20.72B -21.35B -21.33B -20.22B -260M 454M -2.51B -2.79B -2.98B -3.33B -1.16B -1.05B -862M -13.23B -12.45B -12.54B
Purchase of Investments
-1.67B -1.13B -769M -1.11B -1.58B -1.85B -1.77B -1.08B -855M -2.08B -3.59B -5.64B -6.43B -5.89B -5.48B -4.43B -4.56B -4.74B
Sales Maturities Of Investments
1.26B 867M 1.39B 1.16B 1.44B 1.58B 948M 2.12B 3.08B 4.65B 6.63B 8.18B 7.93B 7.69B 6.78B 5.53B 5.53B 6.09B
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-1.39B -2.23B -21.35B -22.5B -22.69B -21.7B -2.29B 264M -1.41B -1.37B -1.06B -1.87B -769M -300M -538M -13.07B -12.3B -11.93B
Debt Repayment
-3.27B -5.49B 10.1B 12.6B 15.24B 17.92B 456M -1.51B -4.36B -7.02B -5.31B -5.56B -3.06B -1.4B -6.18B -376M -1.76B -682M
Common Stock Repurchased
n/a n/a n/a n/a -4B -4.91B -5.16B -7.57B -4.16B -3.25B -8B -8.34B -8.28B -9.51B -6.29B -5B -4.48B -3.24B
Dividend Paid
-4.95B -4.91B -4.86B -4.8B -4.78B -4.76B -4.74B -4.73B -4.69B -4.64B -4.63B -4.59B -4.52B -4.47B -4.4B -4.32B -4.24B -4.17B
Other Financial Acitivies
-95M -112M -106M -62M -37M 22M 27M 181M 193M 559M 984M 802M 945M 802M 641M 921M 896M 696M
Financial Cash Flow
-8.32B -10.51B 5.13B 7.74B 6.43B 8.28B -9.42B -13.63B -13.01B -14.36B -16.96B -17.68B -14.92B -14.58B -16.22B -8.77B -9.58B -7.39B
Net Cash Flow
6.32B 1.54B -1.17B 325M -2.13B 286M 2.19B -389M -2.54B -3.53B -4.99B -5.92B -437M 1.26B -657M -5.98B -8.96B -4.92B
Free Cash Flow
14.58B 13.09B 13.94B 13.8B 12.95B 12.51B 12.65B 11.69B 10.72B 11.08B 11.95B 12.72B 14.28B 15.14B 15.23B 14.88B 12B 13.51B